Yee-Joo Tan

Associate Professor

National University of Singapore (NUS)

Singapore

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Yee-Joo Tan is an Associate Professor at the National University of Singapore. His research primarily focuses on virology, specifically involving monoclonal antibodies for hepatitis B and influenza viruses, and the immune response to SARS-CoV-2. He has contributed significantly to the understanding of host phosphosignaling in viral infections and has been involved in the development of therapeutic strategies for pandemic readiness. His recent articles reflect a commitment to advancing diagnostic and therapeutic applications in viral diseases.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Pedro Abizanda Soler

Professor of Geriatric Medicine

University of Castilla-La Mancha

SPAIN

View details

Hyungwon Choi

Associate Professor

National University of Singapore (NUS)

SINGAPORE

View details

Silvia Ottaviani

Honorary Lecturer

Imperial College London

UNITED KINGDOM

View details

Christian Sommerauer

Karolinska Institutet

SWEDEN

View details

Fernando Andres-Pretel

Associate Professor

Universidad de Castilla-La Mancha - Campus de Albacete

SPAIN

View details

Agata Blasiak

Research Assistant Professor

National University Singapore Yong Loo Lin School of Medicine

SINGAPORE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yee-Joo Tan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Development of monoclonal antibodies to target the large surface protein of hepatitis B virus and their use in therapeutic and diagnostic applications

The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens

Switching Heavy Chain Constant Domains Denatures the Paratope 3D Architecture of Influenza Monoclonal Antibodies

Phosphoproteomics Unravel HBV Triggered Rewiring of Host Phosphosignaling Events

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality.

Editorial: Host Innate Immune Response and Its Impact on Pulmonary Pathogenesis During Influenza Virus Infection.

Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine.

Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes

Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2

Collaborators (6)

Pedro Abizanda Soler

Hyungwon Choi

Silvia Ottaviani

Christian Sommerauer

Fernando Andres-Pretel

Agata Blasiak

Make your next move.